Thymmune Therapeutics ^Company

Thymmune Therapeutics is a biotechnology company that specializes in developing a machine learning-driven thymic cell engineering platform. Their main goal is to restore normal immune function in aging and disease through this innovative approach. By utilizing iPSC-thymic cell manufacturing, they are able to generate off-the-shelf cells at scale. Thymmune Therapeutics is currently focused on developing a pipeline of therapies to treat immunodeficiencies, transplant-related, and autoimmune disorders. Their cutting-edge technology has the potential to revolutionize the field of immunotherapy and improve the lives of patients suffering from various immune-related conditions.